Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand | Zendy

Pornpan Koomanachai | Zendy; Surapee Tiengrim | Zendy; Pattarachai Kiratisin | Zendy; Visanu Thamlikitkul | Zendy

Open Access

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

Author(s) -

Pornpan Koomanachai,

Surapee Tiengrim,

Pattarachai Kiratisin,

Visanu Thamlikitkul

Publication year - 2007

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2006.09.011

Subject(s) - colistin , acinetobacter baumannii , pseudomonas aeruginosa , medicine , acinetobacter , multiple drug resistance , microbiology and biotechnology , intensive care medicine , antibiotics , biology , bacteria , genetics

To determine the efficacy and safety of colistin (colistimethate sodium) produced by a local pharmaceutical company in Thailand for the treatment of infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa and Acinetobacter baumannii.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research